Introduction: Treatment of localized prostate cancer refers to two basic modes which are the radical retro pubic prostatectomy and external radiotherapy. However, according to most authors, radical prostatectomy is the gold standard for long-term survival. Objective: To determine the occurrence of erectile dysfunction after radical operative treatment and irradiation therapy. Material and methods: In this paper we have examined the occurrence of erectile dysfunction after conducted treatment for localized prostate cancer. In this paper we have examined 84 of 138 patients who underwent radical retro pubic prostatectomy at the Urology Clinic in the period from January 2009 to December 2010 and 26 patients wh
BACKGROUND: Although urinary adverse events after treatment of prostate cancer (CaP) are common, pop...
Introduction: The incidence of erectile dysfunction in men following radical prostatectomy has been ...
Radical prostatectomy remains the standard treatment for men with clinically localized prostate canc...
There has been a great evolution in the field of male erectile dysfunction after the establishment o...
The true causes of sexual disorders after radiation treatment of prostate cancer, among which the ce...
Prostate cancer is the most common cancer to affect men in the UK. Treatment options depend on the g...
textabstractQuality of life in general and sexual functioning in particular have become very importa...
In recent years, significant changes have taken place in the treatment of prostate cancer. Modern ra...
Background: Sexual dysfunction is an important side-effect after radiotherapy (RT) for prostate canc...
Sexual dysfunction is very common after treatment of prostate cancer. Radiation therapy together wit...
OBJECTIVES: Although the high rate of erectile dysfunction (ED) following prostatectomy is well reco...
BackgroundErectile dysfunction (ED) after treatment for prostate cancer with radiotherapy (RT) is we...
Erectile dysfunction is a recognized complication of prostate and bladder radical surgery, although ...
The purpose of our research is to improve the quality of life of patients undergoing radical prostat...
With increasing scrutiny of prostate cancer (PCa) diagnosis and treatment, much attention has been g...
BACKGROUND: Although urinary adverse events after treatment of prostate cancer (CaP) are common, pop...
Introduction: The incidence of erectile dysfunction in men following radical prostatectomy has been ...
Radical prostatectomy remains the standard treatment for men with clinically localized prostate canc...
There has been a great evolution in the field of male erectile dysfunction after the establishment o...
The true causes of sexual disorders after radiation treatment of prostate cancer, among which the ce...
Prostate cancer is the most common cancer to affect men in the UK. Treatment options depend on the g...
textabstractQuality of life in general and sexual functioning in particular have become very importa...
In recent years, significant changes have taken place in the treatment of prostate cancer. Modern ra...
Background: Sexual dysfunction is an important side-effect after radiotherapy (RT) for prostate canc...
Sexual dysfunction is very common after treatment of prostate cancer. Radiation therapy together wit...
OBJECTIVES: Although the high rate of erectile dysfunction (ED) following prostatectomy is well reco...
BackgroundErectile dysfunction (ED) after treatment for prostate cancer with radiotherapy (RT) is we...
Erectile dysfunction is a recognized complication of prostate and bladder radical surgery, although ...
The purpose of our research is to improve the quality of life of patients undergoing radical prostat...
With increasing scrutiny of prostate cancer (PCa) diagnosis and treatment, much attention has been g...
BACKGROUND: Although urinary adverse events after treatment of prostate cancer (CaP) are common, pop...
Introduction: The incidence of erectile dysfunction in men following radical prostatectomy has been ...
Radical prostatectomy remains the standard treatment for men with clinically localized prostate canc...